Two examples highlighting how decision-making tools are developing from curated genomic data to improve clinical implementation of precision medicine.
New Interpretation and Reporting Tools Developing from Curated Genomic Data Read More »
Where AI and molecular testing are showing new methods of detecting pancreatic cancers before they become more advanced.
Research team identifies five disease cohort categories for which voice changes have been associated with specific diseases with well-recognized unmet needs.
Watching a new set of genes for ALS treatment connections, using remote sleep monitoring for detecting Parkinson’s breathing patterns, plus a major investment.
More states are focusing on cancer biomarker testing for payer coverage requirements.
New microbiome study shows that genes impact what types of bacteria are present in the intestines, creating new implications for neurological and emotional health.
Recent research into liquid biopsies has resulted in a new blood test that can detect liver cancer while it is still in an early stage.
Diagnostic yield in larger gene panel testing, ambitious goals for gene editing, and gauging demand for genetic testing in the community.
Several recent advances in wearable technologies may mean that healthcare leaders are getting closer to seeing wearables as a core part of precision medicine.
Recent Advancements in Medical Wearables Will Impact the Future of Precision Medicine Read More »
After a multimillion-dollar investment of public funding for early implementation of rapid whole genome sequencing (rWGS), those at the forefront release progress.
Update on Pediatric Medicine Trend in Rapid Diagnostics Read More »
